Aspira Pathlab & Diagnostics Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

13.20

14.46

19.54

15.21

8.42

Operating profit

-1.19

1.59

6.36

3.51

-1.86

Interest

0.37

0.42

0.37

0.89

1.01

Gross profit

-1.13

1.50

6.10

2.83

-2.58

EPS (Rs)

-2.60

-0.09

4.33

1.34

-4.56

Other income

0.42

0.32

0.10

0.20

0.29

Stock adjustment

-

-

-

-

-

Raw material

2.62

2.50

3.14

2.63

1.99

Power and fuel

-

-

-

-

-

Employee expenses

6.20

5.59

5.02

4.03

4.95

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

5.57

4.77

5.02

5.03

3.34

Provisions made

-

-

-

-

-

Depreciation

1.54

1.59

1.64

1.44

1.66

Taxation

-

-

-

-

-

Net profit / loss

-2.67

-0.09

4.46

1.38

-4.24

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

10.29

10.29

10.29

10.29

9.29

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-8.99

11.02

32.57

23.11

-22.06

GPM (%)

-8.32

10.13

31.03

18.34

-29.64

NPM (%)

-19.61

-0.60

22.70

8.96

-48.72